Orthofix Int'l (OFIX) Prelim. FY15 Revenue Edges-Out Expectations

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. ANT
3. SPY
4. FFR
5. FFAI
6. TSLA
7. META
8. FICO
9. CART
10. LLY

Go back to Orthofix Int'l (OFIX) Prelim. FY15 Revenue Edges-Out Expectations

Orthofix Announces Preliminary Fourth Quarter 2015 and Full Year Net Sales Results

January 12, 2016 4:00 PM EST

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V. (NASDAQ: OFIX), a diversified, global medical device company, today announced preliminary unaudited fourth quarter 2015 net sales of approximately $105 million. These preliminary results represent a reported sales growth of 4.3% and constant currency sales growth of 7.6% over the fourth quarter 2014. For the full year 2015, preliminary unaudited net sales were approximately $396 million, which decreased 1.4% on a reported basis and increased 2.4% on a constant currency basis over the full year 2014.

    Three Months Ended December 31, (Unaudited, U.S. Dollars, in millions)

2015

    2014    

ReportedGrowth

   

ConstantCurrencyGrowth

BioStim

$

45

$ 40  

13

%  

13

% Biologics... More